JPWO2025121339A5 - - Google Patents

Info

Publication number
JPWO2025121339A5
JPWO2025121339A5 JP2025531372A JP2025531372A JPWO2025121339A5 JP WO2025121339 A5 JPWO2025121339 A5 JP WO2025121339A5 JP 2025531372 A JP2025531372 A JP 2025531372A JP 2025531372 A JP2025531372 A JP 2025531372A JP WO2025121339 A5 JPWO2025121339 A5 JP WO2025121339A5
Authority
JP
Japan
Prior art keywords
liposome
pegylated
preparation according
lipid
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025531372A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2025121339A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2024/042812 external-priority patent/WO2025121339A1/ja
Publication of JPWO2025121339A1 publication Critical patent/JPWO2025121339A1/ja
Publication of JPWO2025121339A5 publication Critical patent/JPWO2025121339A5/ja
Pending legal-status Critical Current

Links

JP2025531372A 2023-12-04 2024-12-04 Pending JPWO2025121339A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023204574 2023-12-04
PCT/JP2024/042812 WO2025121339A1 (ja) 2023-12-04 2024-12-04 リポソーム剤、ｎｋｔ細胞活性化剤、医薬組成物、およびこれらの用途

Publications (2)

Publication Number Publication Date
JPWO2025121339A1 JPWO2025121339A1 (https=) 2025-06-12
JPWO2025121339A5 true JPWO2025121339A5 (https=) 2025-12-16

Family

ID=95979951

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025531372A Pending JPWO2025121339A1 (https=) 2023-12-04 2024-12-04

Country Status (2)

Country Link
JP (1) JPWO2025121339A1 (https=)
WO (1) WO2025121339A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201442739A (zh) * 2013-02-27 2014-11-16 Riken 過敏疾病治療藥
JP2018070576A (ja) * 2016-11-04 2018-05-10 竜弘 石田 ＣＤ１ｄリガンドとがん抗原を含有するポリエチレングリコール（ＰＥＧ）修飾の中性リポソームを有効成分とする抗がん剤組成物
KR20210061393A (ko) * 2018-09-18 2021-05-27 유니버시테이트 젠트 치료용 나노입자 및 이의 사용 방법
AU2020384481B2 (en) * 2019-11-12 2025-12-11 Nammi Therapeutics, Inc. Formulated and/or co-formulated liposome compositions containing IDO antagonist prodrugs useful in the treatment of cancer and methods thereof
JP7829485B2 (ja) * 2019-12-20 2026-03-13 ナミ セラピューティクス， インコーポレイテッド がんの処置において有用なＴｏｌｌ様受容体（「ＴＬＲ」）アゴニストプロドラッグを含有する製剤化および／または共製剤化リポソーム組成物ならびにその方法

Similar Documents

Publication Publication Date Title
EP3252043B1 (en) Cationic lipid
KR102385562B1 (ko) Rna 전달을 위한 이온화가능한 양이온성 지질
CA2980721C (en) Nucleic acid-containing lipid nanoparticles
KR100386002B1 (ko) 소수성탁산유도체
EP2718261B1 (en) Compounds for targeting drug delivery and enhancing sirna activity
TW202248190A (zh) 脂質化合物、其組合物、其藥物組合物、製備脂質奈米顆粒的方法及其用途
JP7741872B2 (ja) 化合物またはその塩、脂質粒子および医薬組成物
WO2012119781A2 (en) Novel lipids, phospholipids, phospholipid and lipid compositions and their use
CN101579314A (zh) 有机-无机复合脂质体的抗癌药物缓释制剂及其制备方法
TW202600533A (zh) 可離子化脂質及其用途
IL323753A (en) Amino lipid, and lipid nanoparticles and use thereof
CN121889371A (zh) 脂质及其组合物
WO2024019770A1 (en) Methods of making ionizable lipids and lipid nanoparticles for mrna delivery
TW201619137A (zh) 陽離子性脂質
JPWO2025121339A5 (https=)
EP4635939A1 (en) Novel lipid compound and lipid nanoparticle composition comprising same
TW202525812A (zh) 可離子化脂質及其用途
KR20250087641A (ko) 생물 활성 성분을 전달하기 위한 아미노 지질 화합물 및 지질 나노입자
KR20240088561A (ko) 신규한 지질 화합물 및 이를 포함하는 지질 나노입자 조성물
CN117534585A (zh) 一种新型可电离阳离子脂质化合物及其制备方法与应用
EP1005466A1 (de) Tetraetherlipidderivate und tetraetherlipidderivate enthaltende liposomen und lipidagglomerate sowie deren verwendung
KR100423102B1 (ko) 항암활성을 가지는 파이토스핑고신 유도체
CN116854606B (zh) 一种阳离子脂质化合物及其组合物和用途
EP4484413A1 (en) Dendron-like lipid compound, liposome, lipid complex, and lipid nanoparticle and use thereof
EP4556460A1 (en) Amino lipid compound, preparation method therefor, composition thereof and application thereof